Volumen 2, Ausgabe 3 (2012)
Forschungsupdate
HIV Vaccine Trials Network: activities and achievements of the first decade and beyond
James G Kublin, Cecilia A Morgan, Tracey A Day, Peter B Gilbert, Steve G Self, M Juliana McElrath & Lawrence Corey
Interview
Perspective on Adaptive Designs: 4 years European Medicines Agency reflection paper, 1 year draft US FDA guidance: where are we now?
Brenda Gaydos, Armin Koch, Frank Miller, Martin Posch, Marc Vandemeulebroecke, Sue-Jane Wang
Therapeutische Perspektive
Therapeutic potential of c-MET inhibitors: background and clinical data
Shawna Leslie Organ, J Rafael Sierra,Ming-Sound Tsao
Klinische Trail-Perspektive
Statistical design and analysis issues for the ARDS clinical trials network: the Coordinating Center perspective
David Schoenfeld
Klinische Trail-Perspektive
Assessment of suicidal ideation and behavior in clinical trials: challenges & controversies
Glenn Melvin
Forschungsupdate
Developing a multidisciplinary network for clinical research on HIV infection: the EuroCoord experience
Frank de Wolf, Caroline Sabin, Ole Kirk, Claire Thorne, Genevieve Chene,Kholoud Porter
Rückblick: Ergebnisse klinischer Studien
Irreversible EGFR inhibitors in advanced non-small-cell lung carcinoma: rationale and clinical evidence
Deme John Karikios & Michael Joseph Boyer
Sonderbericht
The views of older people and carers on participation in clinical trials: the PREDICT Study
Frank Balis
Klinische Trail-Perspektive
Challenges of developing new drugs for childhood cancers
Frank M Balis, Elizabeth Fox
